Heart Failure Progression in Hypertrophic Cardiomyopathy　– Possible Insights From Cardiopulmonary Exercise Testing

Heart Failure Progression in Hypertrophic Cardiomyopathy　– Possible Insights From Cardiopulmonary Exercise Testing –

Published:2016 Issue:10 Volume:80 Page:2204-2211
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Magrì Damiano¹,Re Federica²,Limongelli Giuseppe³,Agostoni Piergiuseppe⁴⁵,Zachara Elisabetta²,Correale Michele⁶,Mastromarino Vittoria¹,Santolamazza Caterina¹,Casenghi Matteo¹,Pacileo Giuseppe³,Valente Fabio³,Morosin Marco⁴⁷,Musumeci Beatrice¹,Pagannone Erika¹,Maruotti Antonello⁸⁹,Uguccioni Massimo²,Volpe Massimo¹¹⁰,Autore Camillo¹

Affiliation:

1. Department of Clinical and Molecular Medicine, University of Rome “La Sapienza”

2. Cardiology Division, Cardiac Arrhythmia Center and Cardiomyopathies Unit, San Camillo–Forlanini Hospital

3. Cardiology SUN, Monaldi Hospital, II University of Naples

4. “Monzino” Cardiologic Center, IRCCS

5. Department of Clinical Sciences and Community Health, University of Milan

6. Department of Cardiology, University of Foggia

7. Cardiovascular Department, “Ospedali Riuniti” Trieste and Postgraduate School Cardiovascular Sciences, University of Trieste

8. Department of Economic, Political Sciences and Modern Languages “Libera Università-SS Maria Assunta”

9. Centre for Innovation and Leadership in Health Sciences, University of Southampton

10. IRCCS–Neuromed

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/10/80_CJ-16-0432/_pdf

Reference40 articles.

1. 1. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013; 381: 242–255.

2. 2. Maron BJ. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy. Circ J 2010; 74: 2271–2282.

3. 3. O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al; Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J 2014; 35: 2010–2020.

4. 4. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124: 2761–2796.

5. 5. Authors/Task Force members,Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733–2779.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development a nomogram prognostic model for survival in heart failure patients based on the HF-ACTION data;BMC Medical Informatics and Decision Making;2024-07-19

2. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-04

3. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-06

4. Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study;Journal of Clinical Medicine;2024-04-17

5. Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy;JACC: Heart Failure;2024-01